Organization and Business - Narrative (Details) $ in Thousands |
1 Months Ended | |
|---|---|---|
|
Jun. 30, 2022
inhibitor
numberOfLicensedCompound
|
Oct. 31, 2020
USD ($)
|
|
| Business Acquisition [Line Items] | ||
| Number of licensed compounds | numberOfLicensedCompound | 2 | |
| Number of inhibitors | inhibitor | 2 | |
| CPM Acquisition | ||
| Business Acquisition [Line Items] | ||
| Total consideration | $ | $ 2,500 | |
| X | ||||||||||
- Definition Number Of Inhibitors No definition available.
|
| X | ||||||||||
- Definition Number Of Licensed Compounds No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|